Recently, at the invitation of Indonesia's Cipto Mangkunkusumo National General Hospital, the left ventricular support team from the National Cardiovascular Center and Fuwai Hospital of the Chinese Academy of Medical Sciences rushed to Indonesia to successfully implant a left ventricular assist device for a patient with terminal severe heart failure using a third-generation implantable full magnetic levitation artificial heart developed independently by a Shenzhen company. This operation is the first artificial heart implantation in Indonesia, and the first successful implementation of the “Chinese Treatment Plan” for artificial heart in ASEAN countries.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.